Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

International Nursing Organizations II01:28

International Nursing Organizations II

The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

XRISE-M: X-radiography facility for solidification and diffusion studies of alloys aboard sounding rockets.

The Review of scientific instruments·2020
Same author

ARTEC-A furnace module for directional solidification and quenching experiments in microgravity.

The Review of scientific instruments·2020
Same author

Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Canadian respiratory journal·2012
Same author

Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2011
Same author

Limestone concretions at the ends of the fingers.

Annales de dermatologie et de syphiligraphie·2010
Same author

Management of chronic bronchitis and acute exacerbations of chronic bronchitis.

International journal of antimicrobial agents·2008

関連する実験動画

Updated: Jul 20, 2026

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

マラリア. マラリア. WHOはマラリアを逆転させることができるのか?

M Balter

    Science (New York, N.Y.)
    |February 24, 2001
    PubMed
    まとめ

    世界保健機関 (WHO) は,マラリアによる死亡を10年以内に半分に減らすために1998年にRoll Back Malariaを立ち上げました. 専門家は,この野心的な目標は達成可能だと考えているが,その実現可能性を疑う者もいる.

    科学分野:

    • グローバル・ヘルス・イニシアティブ
    • 感染症のコントロール
    • 公共衛生政策 公共衛生政策とは

    背景:

    • 世界保健機関 (WHO) は,1998年10月に,マラリアを食い止めるキャンペーンを開始した.
    • 主な目標は,10年以内に世界のマラリア死亡率を50%削減することでした.

    さらに関連する動画

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
    03:07

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

    Published on: July 12, 2024

    関連する実験動画

    Last Updated: Jul 20, 2026

    Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
    13:48

    Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

    Published on: June 24, 2012

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
    03:07

    Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

    Published on: July 12, 2024